Healthy Skepticism Library item: 8569

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Response of the American Pharmaceutical Association to the June 14, 1974, inquiry of the Federal Trade Commission.
J Am Pharm Assoc 1974 Oct; 14:(10):538-42,

Abstract:

The full text of the American Pharmaceutical Association’s response to the June 14, 1974, inquiry of the Federal Trade Commission concerning prescription drug pricing is presented. APhA cites the current discussions of the need for increased prescription drug price information and the desirability of prescription drug advertising and price posting, as advocated by the FTC, as revealing an unfortunate and unhealty public knowledge gap regarding the nature and importance of the pharmacist’s professional services which extend beyond the prescription drug as a commodity. The APhA advocates direct pharmacist response to patient’s inquiries as the method which is most truthful, useful, least costly, and not otherwise detrimental to the interests of the profession of pharmacy or the public in providing and receiving high quality pharmaceutical information.

Keywords:
Advertising Costs and Cost Analysis Drug Industry Government Agencies Pharmaceutical Preparations* Pharmacies* Pharmacists Prescriptions, Drug Societies, Pharmaceutical United States